Vaishali Pharma Limited (NSE:VAISHALI)
India · Delayed Price · Currency is INR 6.87
-0.36 (-4.98%)
Oct 23, 2026, 3:29 PM IST
Vaishali Pharma Market Cap
Vaishali Pharma has a market cap or net worth of 896.27 million as of October 23, 2026. It is the 41,460th most valuable company in the world and the 3,366th biggest in India. Its market cap has decreased by 33.37% in one year.
Market Cap
896.27M
Enterprise Value
1.07B
Revenue
1.08B
Global Rank
Country Rank
#3,366 India
PE Ratio
20.27
ChartMarket Cap Chart
Since October 11, 2017, Vaishali Pharma's market cap has increased from 286.62M to 896.27M, an increase of 212.71%. That is a compound annual growth rate of 13.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 896.27M | -20.30% |
| Dec 31, 2025 | 1.12B | -46.84% |
| Dec 31, 2024 | 2.12B | 9.71% |
| Dec 29, 2023 | 1.93B | 31.85% |
| Dec 30, 2022 | 1.46B | 286.75% |
| Dec 31, 2021 | 378.08M | -48.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bafna Pharmaceuticals | 10.91B |
| Sigachi Industries | 9.98B |
| Valiant Laboratories | 7.26B |
| Amanta Healthcare | 6.22B |
| Nectar Lifesciences | 2.19B |
| Brooks Laboratories | 1.79B |
| Par Drugs and Chemicals | 1.29B |
| Balaxi Pharmaceuticals | 1.16B |